To see the other types of publications on this topic, follow the link: Boron-neutron capture therapy.

Journal articles on the topic 'Boron-neutron capture therapy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Boron-neutron capture therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Taskaev, S. Yu. "Boron Neutron Capture Therapy." Physics of Atomic Nuclei 84, no. 2 (March 2021): 207–11. http://dx.doi.org/10.1134/s106377882101021x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

ONO, Koji, Minoru SUZUKI, Shinichiro MASUNAGA, Natsuko KONDO, Yoshinori SAKURAI, Hiroki TANAKA, Yuko KINASHI, and Akira MARUHASHI. "Boron Neutron Capture Therapy." RADIOISOTOPES 61, no. 4 (2012): 209–22. http://dx.doi.org/10.3769/radioisotopes.61.209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

FREEMANTLE, MICHAEL. "BORON NEUTRON CAPTURE THERAPY." Chemical & Engineering News 80, no. 34 (August 26, 2002): 13. http://dx.doi.org/10.1021/cen-v080n034.p013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Beddoe, A. H. "Boron neutron capture therapy." British Journal of Radiology 70, no. 835 (July 1997): 665–67. http://dx.doi.org/10.1259/bjr.70.835.9245876.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Slatkin, Daniel N. "Boron neutron-capture therapy." Neutron News 1, no. 4 (January 1990): 25–28. http://dx.doi.org/10.1080/10448639008229357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ota, Ichiro, and Tadashi Kitahara. "Boron Neutron Capture Therapy (BNCT)." Practica Oto-Rhino-Laryngologica 107, no. 12 (2014): 937–46. http://dx.doi.org/10.5631/jibirin.107.937.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

&NA;. "Improving boron neutron capture therapy." Inpharma Weekly &NA;, no. 971 (January 1995): 8. http://dx.doi.org/10.2165/00128413-199509710-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mumot, M. "325. Boron Neutron Capture Therapy." Reports of Practical Oncology & Radiotherapy 8 (2003): S354—S355. http://dx.doi.org/10.1016/s1507-1367(03)70808-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kato, I. "S17.1 Boron neutron capture therapy." Oral Oncology Supplement 1, no. 1 (January 2005): 63. http://dx.doi.org/10.1016/s1744-7895(05)80118-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Monti, V., M. Costa, E. Durisi, E. Mafucci, A. Calamida, A. I. Castro Campoy, A. Fontanilla, L. Russo, and R. Bedogni. "Neutron spectroscopy for Boron Neutron Capture Therapy beams characterization." Journal of Instrumentation 19, no. 05 (May 1, 2024): C05036. http://dx.doi.org/10.1088/1748-0221/19/05/c05036.

Full text
Abstract:
Abstract Boron Neutron Capture Therapy (BNCT) is a therapeutic treatment for malignant tumors that utilizes the nuclear reactions that happen when thermal neutrons are captured by boron-10 atoms to selectively destroy designated cells. Boron-10 atoms are biochemically accumulated inside the tumor target, which is then irradiated with thermal neutrons. In recent years, the possibility to obtain accelerator based intense neutron beams has given a boost to the diffusion of BNCT also in Europe, removing the need of nuclear reactors. In this contest, the monitoring and characterization of the epithermal neutron beams dedicated to BNCT becomes an important issue. The directional neutron spectrometer called NCT-WES (Neutron Capture Therapy Wide Energy Spectrometer) is a single moderator neutron spectrometer composed of a polyethylene cylinder embedding six semiconductor-based detectors positioned at different depths along the cylinder axes. The position of the six detectors is studied in order to maximize the response of each one in a selected neutron energy range. The unfolding of the six simultaneous readings allows to reconstruct the incoming neutron energy spectrum as in a parallelized Bonner Sphere System. A cylindrical collimator situated in the front of the spectrometer makes the instrument sensitive to neutrons coming only from a given direction, which allows to exclude the contribution of the room scattered radiation. The experimental validation of the spectrometer, obtained through several measuring campaigns, is reported and discussed.
APA, Harvard, Vancouver, ISO, and other styles
11

Sauerwein, Wolfgang A. G., Lucie Sancey, Evamarie Hey-Hawkins, Martin Kellert, Luigi Panza, Daniela Imperio, Marcin Balcerzyk, et al. "Theranostics in Boron Neutron Capture Therapy." Life 11, no. 4 (April 10, 2021): 330. http://dx.doi.org/10.3390/life11040330.

Full text
Abstract:
Boron neutron capture therapy (BNCT) has the potential to specifically destroy tumor cells without damaging the tissues infiltrated by the tumor. BNCT is a binary treatment method based on the combination of two agents that have no effect when applied individually: 10B and thermal neutrons. Exclusively, the combination of both produces an effect, whose extent depends on the amount of 10B in the tumor but also on the organs at risk. It is not yet possible to determine the 10B concentration in a specific tissue using non-invasive methods. At present, it is only possible to measure the 10B concentration in blood and to estimate the boron concentration in tissues based on the assumption that there is a fixed uptake of 10B from the blood into tissues. On this imprecise assumption, BNCT can hardly be developed further. A therapeutic approach, combining the boron carrier for therapeutic purposes with an imaging tool, might allow us to determine the 10B concentration in a specific tissue using a non-invasive method. This review provides an overview of the current clinical protocols and preclinical experiments and results on how innovative drug development for boron delivery systems can also incorporate concurrent imaging. The last section focuses on the importance of proteomics for further optimization of BNCT, a highly precise and personalized therapeutic approach.
APA, Harvard, Vancouver, ISO, and other styles
12

Edgecock, Rob. "Accelerator-driven boron neutron capture therapy." International Journal of Modern Physics A 29, no. 14 (May 26, 2014): 1441004. http://dx.doi.org/10.1142/s0217751x14410048.

Full text
Abstract:
Boron Neutron Capture Therapy is a binary treatment for certain types of cancer. It works by loading the cancerous cells with a boron-10 carrying compound. This isotope has a large cross-section for thermal neutrons, the reaction producing a lithium nucleus and alpha particle that kill the cell in which they are produced. Recent studies of the boron carrier compound indicate that the uptake process works best in particularly aggressive cancers. Most studied is glioblastoma multiforme and a trial using a combination of BNCT and X-ray radiotherapy has shown an increase of nearly a factor of two in mean survival over the state of the art. However, the main technical problem with BNCT remains producing a sufficient flux of neutrons for a reasonable treatment duration in a hospital environment. This paper discusses this issue.
APA, Harvard, Vancouver, ISO, and other styles
13

Wuu, C. S., H. I. Amols, P. Kliauga, L. E. Reinstein, and S. Saraf. "Microdosimetry for Boron Neutron Capture Therapy." Radiation Research 130, no. 3 (June 1992): 355. http://dx.doi.org/10.2307/3578381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Barth, Rolf F., Albert H. Soloway, and Ralph G. Fairchild. "Boron Neutron Capture Therapy for Cancer." Scientific American 263, no. 4 (October 1990): 100–107. http://dx.doi.org/10.1038/scientificamerican1090-100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Sauerwein, Wolfgang. "81 Boron neutron capture therapy (BNCT)." Radiotherapy and Oncology 40 (January 1996): S23. http://dx.doi.org/10.1016/s0167-8140(96)80088-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Barth, Rolf F., and Albert H. Soloway. "Perspective on boron neutron capture therapy." International Journal of Radiation Oncology*Biology*Physics 28, no. 5 (March 1994): 1059–60. http://dx.doi.org/10.1016/0360-3016(94)90478-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Yamamoto, Tetsuya, Kei Nakai, and Akira Matsumura. "Boron neutron capture therapy for glioblastoma." Cancer Letters 262, no. 2 (April 2008): 143–52. http://dx.doi.org/10.1016/j.canlet.2008.01.021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Hatanaka, H. "Boron neutron capture therapy for tumors." International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes 37, no. 1 (January 1986): 79–80. http://dx.doi.org/10.1016/0883-2889(86)90215-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Hu, Kuan, Zhimin Yang, Lingling Zhang, Lin Xie, Lu Wang, Hao Xu, Lee Josephson, Steven H. Liang, and Ming-Rong Zhang. "Boron agents for neutron capture therapy." Coordination Chemistry Reviews 405 (February 2020): 213139. http://dx.doi.org/10.1016/j.ccr.2019.213139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Salt, C., A. J. Lennox, M. Takagaki, J. A. Maguire, and N. S. Hosmane. "Boron and gadolinium neutron capture therapy." Russian Chemical Bulletin 53, no. 9 (September 2004): 1871–88. http://dx.doi.org/10.1007/s11172-005-0045-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Howard, William Bruce. "Accelerator-based boron neutron capture therapy." Medical Physics 25, no. 6 (June 1998): 1060. http://dx.doi.org/10.1118/1.598286.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

MORRIS, J. H. "ChemInform Abstract: Boron Neutron Capture Therapy." ChemInform 22, no. 32 (August 22, 2010): no. http://dx.doi.org/10.1002/chin.199132313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Metwally, Walid A., Yumna A. Alharahsheh, Entesar Z. Dalah, and Husam Al-Omari. "Utilizing neutron generators in boron neutron capture therapy." Applied Radiation and Isotopes 174 (August 2021): 109742. http://dx.doi.org/10.1016/j.apradiso.2021.109742.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Wolber, Gerd. "Fast Neutron Beams for Boron Neutron Capture Therapy?" Zeitschrift für Medizinische Physik 14, no. 1 (2004): 55–63. http://dx.doi.org/10.1078/0939-3889-00192.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Conte, Valeria, Anna Bianchi, and Anna Selva. "Boron Neutron Capture Therapy: Microdosimetry at Different Boron Concentrations." Applied Sciences 14, no. 1 (December 26, 2023): 216. http://dx.doi.org/10.3390/app14010216.

Full text
Abstract:
This paper explores the role of microdosimetry in boron neutron capture therapy (BNCT), a cancer treatment involving the selective accumulation of boron-containing compounds in cancer cells, followed by neutron irradiation. Neutron interactions with 10B induces a nuclear reaction, releasing densely ionizing particles, specifically alpha particles and recoiling lithium-7 nuclei. These particles deposit their energy within a small tissue volume, potentially targeting cancer cells while sparing healthy tissue. The microscopic energy distribution, subject to significant fluctuations due to the short particle range, influences treatment efficacy. Microdosimetry, by studying this distribution, plays a crucial role in optimizing BNCT treatment planning. The methodology employs paired tissue equivalent proportional counters (TEPCs), one with cathode walls enriched with boron and the other without. Precise assessment of boron concentration is essential, as well as the ability to extrapolate results to the actual 10B concentration within the treatment region. The effective 10B concentrations within four boronated TEPCs, containing 10, 25, 70, and 100 ppm of 10B, have been determined. Results show variations of less than 3% from nominal values. Additionally, dose enhancement due to BNC interactions was measured and found to be proportional to the 10B concentration, with a proportionality factor of 7.7 × 10−3 per ppm of boron. Based on these findings, a robust procedure is presented for assessing the impact of BNCT in the treatment region, considering potential variations in boron content relative to the TEPC used.
APA, Harvard, Vancouver, ISO, and other styles
26

Ogura, K., A. Yamazaki, H. Yanagie, M. Eriguchi, E. H. Lehmann, G. Küehne, G. Bayon, K. Maruyama, and H. Kobayashi. "Neutron capture autoradiography for a study on boron neutron capture therapy." Radiation Measurements 34, no. 1-6 (June 2001): 555–58. http://dx.doi.org/10.1016/s1350-4487(01)00227-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Takahashi, Minoru, Tooru Kobayashi, Mingguang Zhang, Michael Mak, Jiri Stefanica, Vaclav Dostal, and Wei Zhao. "ICONE19-43192 STUDY ON HIGH SPEED LITHIUM JET FOR NEUTRON SOURCE OF BORON NEUTRON CAPTURE THERAPY (BNCT)." Proceedings of the International Conference on Nuclear Engineering (ICONE) 2011.19 (2011): _ICONE1943. http://dx.doi.org/10.1299/jsmeicone.2011.19._icone1943_74.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Ailuno, Giorgia, Alice Balboni, Gabriele Caviglioli, Francesco Lai, Federica Barbieri, Irene Dellacasagrande, Tullio Florio, and Sara Baldassari. "Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment." Cells 11, no. 24 (December 13, 2022): 4029. http://dx.doi.org/10.3390/cells11244029.

Full text
Abstract:
Boron neutron capture therapy is a low-invasive cancer therapy based on the neutron fission process that occurs upon thermal neutron irradiation of 10B-containing compounds; this process causes the release of alpha particles that selectively damage cancer cells. Although several clinical studies involving mercaptoundecahydro-closo-dodecaborate and the boronophenylalanine–fructose complex are currently ongoing, the success of this promising anticancer therapy is hampered by the lack of appropriate drug delivery systems to selectively carry therapeutic concentrations of boron atoms to cancer tissues, allowing prolonged boron retention therein and avoiding the damage of healthy tissues. To achieve these goals, numerous research groups have explored the possibility to formulate nanoparticulate systems for boron delivery. In this review. we report the newest developments on boron vehiculating drug delivery systems based on nanoparticles, distinguished on the basis of the type of carrier used, with a specific focus on the formulation aspects.
APA, Harvard, Vancouver, ISO, and other styles
29

Sumitani, Shogo, and Yukio Nagasaki. "Boron neutron capture therapy assisted by boron-conjugated nanoparticles." Polymer Journal 44, no. 6 (April 4, 2012): 522–30. http://dx.doi.org/10.1038/pj.2012.30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Pitto-Barry, Anaïs. "Polymers and boron neutron capture therapy (BNCT): a potent combination." Polymer Chemistry 12, no. 14 (2021): 2035–44. http://dx.doi.org/10.1039/d0py01392g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Susilowati, Anggraeni Dwi, Kusminarto Kusminarto, and Yohannes Sardjono. "Boron Neutron Capture Therapy (BNCT) using Compact Neutron generator." Indonesian Journal of Physics and Nuclear Applications 1, no. 2 (June 30, 2016): 73. http://dx.doi.org/10.24246/ijpna.v1i2.73-80.

Full text
Abstract:
<span>Boron Neutron Capture Therapy (BNCT) must be appropriate with five criteria from IAEA. These criteria in order to prevent neutron beam output harm the patient. It can be by using Collimator of neutron source Compact Neutron Generator (CNG) and Monte Carlo simulation method with N particles 5 .CNG is developed by deuteriumtritium reaction (DT) and deuterium-deuterium (DD) reaction. The manufacture result of the collimator is obtained </span><span>epithermal neutron flux value of 1.69e-9 n/cm^2s for D-T reaction and 8e6 n/cm^2s for D-D reaction, ratio of epithermal and thermal is 1.95e-13 Gy cm^2/n for D-T reaction and for D-D reaction, ratio of fast neutron component is 1.69e-13 Gy cm^2/n for D-T reaction and for D-D reaction, ratio of gamma component is 1.18e-13 Gy cm^2/nfor D-T reaction and for D-D reaction. The Latest </span><span>reaction is current ratio 0.649 for D-T reaction and 0.46 for D-D reaction.</span>
APA, Harvard, Vancouver, ISO, and other styles
32

Kiyanagi, Yoshiaki. "Accelerator-based neutron source for boron neutron capture therapy." Therapeutic Radiology and Oncology 2 (November 2018): 55. http://dx.doi.org/10.21037/tro.2018.10.05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Perks, C. A., and J. A. B. Gibson. "Neutron Spectrometry and Dosimetry for Boron Neutron Capture Therapy." Radiation Protection Dosimetry 44, no. 1-4 (November 1, 1992): 425–28. http://dx.doi.org/10.1093/oxfordjournals.rpd.a081477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Perks, C. A., and J. A. B. Gibson. "Neutron Spectrometry and Dosimetry for Boron Neutron Capture Therapy." Radiation Protection Dosimetry 44, no. 1-4 (November 1, 1992): 425–28. http://dx.doi.org/10.1093/rpd/44.1-4.425.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Kasatov, D., A. Koshkarev, A. Kuznetsov, A. Makarov, Yu Ostreinov, I. Shchudlo, I. Sorokin, T. Sycheva, S. Taskaev, and L. Zaidi. "The accelerator neutron source for boron neutron capture therapy." Journal of Physics: Conference Series 769 (November 2016): 012064. http://dx.doi.org/10.1088/1742-6596/769/1/012064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Zaidi, L., E. A. Kashaeva, S. I. Lezhnin, G. N. Malyshkin, S. I. Samarin, T. V. Sycheva, S. Yu Taskaev, and S. A. Frolov. "Neutron-beam-shaping assembly for boron neutron-capture therapy." Physics of Atomic Nuclei 80, no. 1 (January 2017): 60–66. http://dx.doi.org/10.1134/s106377881701015x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Golubev, S. V., I. V. Izotov, S. V. Razin, A. V. Sidorov, and V. A. Skalyga. "A Compact Neutron Source for Boron Neutron Capture Therapy." Radiophysics and Quantum Electronics 59, no. 8-9 (January 2017): 682–89. http://dx.doi.org/10.1007/s11141-017-9735-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Kim, Woohyoung, Ji Yeong Won, Jungyu Yi, Seung Chan Choi, Sang Min Lee, Kyungran Mun, and Hyeong-Seok Lim. "PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy." Pharmaceuticals 17, no. 3 (February 26, 2024): 301. http://dx.doi.org/10.3390/ph17030301.

Full text
Abstract:
L-4-[(10B)]Boronophenylalanine (BPA) is an amino acid analogue with a boron-10 moiety. It is most widely used as a boron carrier in boron neutron capture therapy. In this study, a Bayesian predictive platform of blood boron concentration based on a BPA pharmacokinetic (PK) model was developed. This platform is user-friendly and can predict the individual boron PK and optimal time window for boron neutron capture therapy in a simple way. The present study aimed to establish a PK model of L-4-boronophenylalanine and develop a Bayesian predictive platform for blood boron PKs for user-friendly estimation of boron concentration during neutron irradiation of neutron capture therapy. Whole blood boron concentrations from seven previous reports were graphically extracted and analyzed using the nonlinear mixed-effects modeling (NONMEM) approach. Model robustness was assessed using nonparametric bootstrap and visual predictive check approaches. The visual predictive check indicated that the final PK model is able to adequately predict observed concentrations. The Shiny package was used to input real-time blood boron concentration data, and during the following irradiation session blood boron was estimated with an acceptably short calculation time for the determination of irradiation time. Finally, a user-friendly Bayesian estimation platform for BPA PKs was developed to optimize individualized therapy for patients undergoing BNCT.
APA, Harvard, Vancouver, ISO, and other styles
39

Minoru, SUZUKI. "New Application for Boron Neutron Capture Therapy." RADIOISOTOPES 64, no. 1 (2015): 59–66. http://dx.doi.org/10.3769/radioisotopes.64.59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Maulana, Indra. "ANIMATION OF BORON NEUTRON CAPTURE CANCER THERAPY." Indonesian Journal of Physics and Nuclear Applications 3, no. 3 (December 22, 2018): 102–12. http://dx.doi.org/10.24246/ijpna.v3i3.102-112.

Full text
Abstract:
One of the most common causes of death in the world is cancer. Scientists have been trying to find the best cure for cancer ever since it was discovered. There are some ways that are used to treat cancer patients. Lately, scientists have developed a new way in treating cancer, it’s called Boron Neutron Capture Therapy (BNCT). BNCT is a selective cancer therapy, it only selects the cancer cells to be treated and leaves the normal cell untouched. It may have no effect or only a little effect on normal cells. As new knowledge that needs to be known by all people, what is the best way to introduce BNCT? What is the best media to introduce BNCT? Is it enough to just read it in a newspaper or in a book? How about using advanced technology such as animation to introduce BNCT? The use of animation as a form of media to introduce something new is already being done in many fields. Can animation be used as a form of media to introduce BNCT too? Will it be effective? By this study, the author gives information about the effect of using animation as a tool to explain and understand BNCT more.
APA, Harvard, Vancouver, ISO, and other styles
41

Kanygin, V. V., E. L. Zavyalov, A. E. Simonovich, A. I. Kichigin, A. I. Kasatova, R. A. Mukhamadiyarov, R. V. Sibirtsev, N. S. Filin, and T. V. Sycheva. "BORON NEUTRON CAPTURE THERAPY OF GLIAL TUMORS." Современные проблемы науки и образования (Modern Problems of Science and Education), no. 3 2019 (2019): 144. http://dx.doi.org/10.17513/spno.28914.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Akan, Zafer. "Boron Neutron Capture Therapy for Breast Cancer." International Journal of Women's Health and Reproduction Sciences 3, no. 2 (February 7, 2015): 77. http://dx.doi.org/10.15296/ijwhr.2015.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Carlsson, Jorgen, Stefan Sjoberg, and Bengt S. Larsson. "Present Status of Boron Neutron Capture Therapy." Acta Oncologica 31, no. 8 (January 1992): 803–13. http://dx.doi.org/10.3109/02841869209089712.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Kabalka, George W. "Recent developments in boron neutron capture therapy." Expert Opinion on Therapeutic Patents 8, no. 5 (May 1998): 545–51. http://dx.doi.org/10.1517/13543776.8.5.545.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Raaijmakers, C. P. J., E. L. Nottelman, B. J. Mijnheer, and E. L. Nottelman. "Phantom materials for boron neutron capture therapy." Physics in Medicine and Biology 45, no. 8 (July 25, 2000): 2353–61. http://dx.doi.org/10.1088/0031-9155/45/8/320.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Walker, Simon J. "Boron neutron capture therapy: principles and prospects." Radiography 4, no. 3 (August 1998): 211–19. http://dx.doi.org/10.1016/s1078-8174(98)80048-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Carlsson, Jörgen, Erika Bohl Kullberg, Jacek Capala, Stefan Sjöberg, Katarina Edwards, and Lars Gedda. "Ligand liposomes and boron neutron capture therapy." Journal of Neuro-oncology 62, no. 1-2 (March 2003): 47–59. http://dx.doi.org/10.1007/bf02699933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Gupta, Nilendu, Reinhard A. Gahbauer, Thomas E. Blue, and André Wambersie. "Dose prescription in boron neutron capture therapy." International Journal of Radiation Oncology*Biology*Physics 28, no. 5 (March 1994): 1157–66. http://dx.doi.org/10.1016/0360-3016(94)90490-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Diaz, Aidnag Z., Jeffrey A. Coderre, Arjun D. Chanana, and Ruimei Ma. "Boron neutron capture therapy for malignant gliomas." Annals of Medicine 32, no. 1 (January 2000): 81–85. http://dx.doi.org/10.3109/07853890008995913.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Rij, Catharina M. van, Abraham J. Wilhelm, Wolfgang A. G. Sauerwein, and Arie C. van Loenen. "Boron neutron capture therapy for glioblastoma multiforme." Pharmacy World & Science 27, no. 2 (April 2005): 92–95. http://dx.doi.org/10.1007/s11096-004-2850-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography